Skip to main content

Nonprofit · EIN 23-1682043

AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS

Tax-exempt · ALEXANDRIA, VA 22314

Financials

$3.7M$4.1M2023$4.3M$4.2M2024
Revenue Expenses · by fiscal year end
Financials of AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$4,291,389$4,166,644$124,745$7,725,742$990,157$6,735,585
December 31, 2023990$3,700,370$4,053,559-$353,189$6,491,449$0$6,491,449
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$313,183
Program service revenue
$3,790,108
Investment income
$96,348
Net gain from sales of assets
-$8,187
Other revenue
$91,750

Expenses

Grants and similar amounts paid
$73,500
Compensation of officers, directors and key employees
$765,472
Other salaries and wages
$906,364
Salaries, compensation and benefits (total)
$1,897,121
Professional fundraising fees
$0
Legal fees
$25,727
Accounting fees
$134,382
Occupancy
$22,124
Travel
$97,988
Depreciation
$83,690
Program services (functional)
$3,642,483
Management and general (functional)
$524,161

Balance sheet and other

Total assets, start of year
$6,491,449
Total assets, end of year
$7,725,742
Total liabilities, end of year
$990,157
Net assets, end of year
$6,735,585
Land, buildings and equipment
$1,420,853
Publicly traded securities
$2,236,658
Net assets without donor restrictions
$5,753,203
Net assets with donor restrictions
$982,382
Gross unrelated business income
$10,904
Gross receipts
$5,281,741
Employees
11
Volunteers
600
Year formed
1900
State of legal domicile
DC

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
ABIGAIL GORMANCHIEF EXECUTIVE OFFICER
Officer
40$410,130$84,562
ELISE LAFFMAN-JOHNSONCHIEF OPERATING OFFICER
Officer
40$240,960$29,819
LISA INFELISESR DIR, MBR SVCS
Highest-paid employee
40$149,328$26,660
ALETHEA GERDINGMANAGING EDITOR
Highest-paid employee
40$126,347$16,036
MATTHEW RIZK PHDPRESIDENT
Trustee or director, Officer
4$0$0
WALTER KRAFT MDIMMEDIATE PAST PRESIDENT
Trustee or director, Officer
4$0$0
MARK DRESSER PHDIMMEDIATE PAST PRES. (UNTIL 3/2024)
Trustee or director, Officer
4$0$0
SANDRA VISSER PHDPRESIDENT-ELECT
Trustee or director, Officer
4$0$0
JACQUES TURGEONTREASURER
Trustee or director, Officer
4$0$0
ANTOINETTE AJAVON-HARTMANN PHDDIRECTOR
Trustee or director
4$0$0
LISA BENINCOSA PHDDIRECTOR
Trustee or director
4$0$0
SHAYNA KILLAM PHARMDDIRECTOR
Trustee or director
4$0$0
JING LIU PHDDIRECTOR
Trustee or director
4$0$0
KATHRYN MOMARY PHARMDDIRECTOR
Trustee or director
4$0$0
DANIELE OUELLET PHDDIRECTOR (UNTIL 4/2024)
Trustee or director
4$0$0
3 more people on this return
NameTitleHours / weekCompensation
LUANA PESCO-KOPLOWITZ MD PHDDIRECTOR (UNTIL 4/2024)
Trustee or director
4$0
ANU RAMAMOORTHY PHDDIRECTOR
Trustee or director
4$0
STEPHANI STANCIL PHDDIRECTOR
Trustee or director
4$0
990 for the year ended December 31, 2023: 15 people
NameTitleHours / weekCompensationOther / benefits
ABIGAIL GORMANCHIEF EXECUTIVE OFFICER
Officer
40$366,589$41,665
ELISE LAFFMAN-JOHNSONCHIEF OPERATING OFFICER
Officer
40$281,675$24,449
LISA INFELISESR DIR, MBR SVCS
Highest-paid employee
40$165,789$24,191
ALETHEA GERDINGMANAGING EDITOR
Highest-paid employee
40$143,521$12,350
WALTER KRAFTPRESIDENT
Trustee or director, Officer
4$0$0
MARK J DRESSERIMMEDIATE PAST PRESIDENT
Trustee or director, Officer
4$0$0
MATTHEW L RIZKPRESIDENT-ELECT
Trustee or director, Officer
4$0$0
JACQUES TURGEONTREASURER
Trustee or director, Officer
4$0$0
ANTOINETTE TONI AJAVON-HARTMANNDIRECTOR
Trustee or director
4$0$0
LISA J BENINCOSADIRECTOR
Trustee or director
4$0$0
JING LIUDIRECTOR
Trustee or director
4$0$0
KATHRYN MOMARYDIRECTOR
Trustee or director
4$0$0
DANIELE OUELLETDIRECTOR
Trustee or director
4$0$0
LUANA PESCO-KOPLOWITZDIRECTOR
Trustee or director
4$0$0
ANU RAMAMOORTHYDIRECTOR
Trustee or director
4$0$0

Address and contacts

Address (IRS master file)
528 N WASHINGTON ST, ALEXANDRIA, VA 22314-2314
Principal officer (990 for 2024)
ABIGAIL W GORMAN, 528 NORTH WASHINGTON STREET, ALEXANDRIA, VA 22314
Signed the 990
ABIGAIL W GORMAN, CHIEF EXECUTIVE OFFICER
Phone
(703) 836-6981
Return prepared by
RSM US LLP

Mission

ADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY.

990 for the year ended December 31, 2024

Program accomplishments

  • ANNUAL MEETING: THE ASCPT ANNUAL MEETING IS AN INTERNATIONAL MEETING THAT ATTRACTS PARTICIPANTS FROM AROUND THE WORLD. A SPECTRUM OF TOPICS RELATING TO THE CONTINUUM OF DRUG DISCOVERY, DEVELOPMENT, REGULATION, AND UTILIZATION ARE DISCUSSED. THE MEETING OFFERS EDUCATIONAL SESSIONS AND POSTER PRESENTATIONS, LECTURES FROM TOP PROFESSIONALS IN THE FIELD, AS WELL AS NETWORKING OPPORTUNITIES WITH CLINICAL PHARMACOLOGISTS AND TRANSLATIONAL SCIENTISTS FROM AROUND THE WORLD.
    Expenses $1,758,472 · grants $73,500 · revenue $1,363,850
  • JOURNAL: CLINICAL PHARMACOLOGY AND THERAPEUTICS (CPT) IS THE AUTHORITATIVE CROSS-DISCIPLINARY JOURNAL IN EXPERIMENTAL AND CLINICAL MEDICINE DEVOTED TO PUBLISHING ADVANCES IN THE NATURE, ACTION, EFFICACY AND EVALUATION OF THERAPEUTICS. JOURNAL: CLINICAL PHARMACOLOGY & THERAPEUTICS: PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY (PSP) IS A TIMELY ONLINE-ONLY CROSS-DISCIPLINARY JOURNAL PUBLISHING ADVANCES IN QUANTITATIVE METHODS AS APPLIED IN PHARMACOLOGY, PHYSIOLOGY AND THERAPEUTICS IN HUMANS. CPT HAS A 2024 IMPACT FACTOR OF 5.5. PSP HAS A 2024 IMPACT FACTOR OF 3.0.CLINICAL AND TRANSLATIONAL SCIENCE (CTS) HIGHLIGHTS ORIGINAL RESEARCH THAT HELPS BRIDGE LABORATORY DISCOVERIES WITH THE DIAGNOSIS AND TREATMENT OF HUMAN DISEASE. CTS HAS A 2024 IMPACT FACTOR OF 2.8.
    Expenses $1,208,270 · revenue $1,870,786
  • MEMBER SERVICES: MEMBERSHIP IN ASCPT OFFERS A NUMBER OF BENEFITS WHICH DIRECTLY IMPACT ITS MEMBERS AND THEIR PROFESSIONAL DEVELOPMENT. IT PROVIDES A VARIETY OF INFORMATION AND TOOLS, SUCH AS THE CPT, PSP AND CTS JOURNALS, WEBINARS, WEBSITE AND EMAIL NEWSLETTER, EDUCATIONAL OPPORTUNITIES, SUCH AS THE ANNUAL MEETING, NETWORKING OPPORTUNITIES, AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES.
    Expenses $675,741 · revenue $544,568

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
23-1682043
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1973
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Health care (E66Z)
Assets (IRS master file)
$7,725,742
Income (IRS master file)
$5,281,741

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$4,291,389$4,166,644$7,725,742XML
990-TDecember 2024–––IRS
990December 2023$3,700,370$4,053,559$6,491,449XML
990-TDecember 2023–––IRS
990December 2022$3,625,776$3,254,073$6,502,007IRS
990-TDecember 2022–––IRS
990December 2021–––IRS
990-TDecember 2021–––IRS
990December 2020–––IRS
990-TDecember 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 23-1682043).

Questions about AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS

What is the EIN of AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS?
The employer identification number (EIN) of AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS is 23-1682043.
Is AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1973.
Are donations to AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS?
The 990 for the year ended December 31, 2024 names ABIGAIL W GORMAN.
Who are the officers and directors of AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS?
The 990 for the year ended December 31, 2024 lists 18 people; 4 received compensation from the organization, the highest $410,130 (ABIGAIL GORMAN, CHIEF EXECUTIVE OFFICER).
How much revenue does AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS have?
On its 990 for the year ended December 31, 2024 it reported revenue of $4,291,389, expenses of $4,166,644 and total assets of $7,725,742 at year end.

Other nonprofits in ALEXANDRIA

All nonprofits in ALEXANDRIA · Virginia · Health care